Physician profile
Michael A Chizner
NPI 1679537583
$1,813.15
in general payments reported to CMS, 2019-2025
11 companies · $36.99 in 2025
The $36.99 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2020: $30.00 · 2022: $142 · 2023: $42.60 · 2024: $574 · 2025: $36.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $839.46 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $361.24 | 2022-2024 | Andexxa, Farxiga |
| Boston Scientific Corporation | $303.33 | 2019-2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $69.55 | 2019 | |
| Philips North America LLC | $59.14 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $36.99 | 2025 | Uptravi |
| Amarin Pharma, INC. | $32.50 | 2019 | |
| Bard Peripheral Vascular, INC. | $30.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $29.24 | 2023-2024 | |
| Analog Devices INC. | $28.27 | 2024 | Sensinel Cpm Wearable |
| Amgen INC. | $23.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chizner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.